Kemal Balic
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Fibroblast Growth Factor Research 3
- Co-authors
- Anton I. Rosenbaum (4 shared papers)Meina Liang (5 shared papers)Mayukh Das (1 shared paper)Antoinette R. Tan (1 shared paper)Manish R. Patel (1 shared paper)Mark D. Pegram (1 shared paper)Anna Maria Storniolo (1 shared paper)Erika Hamilton (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Molecular Cancer Therapeutics (1 paper)Scientific Reports (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)Analytical Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Kemal Balic
12 papers receiving 188 citations
Peers
Comparison fields: 5 of 42
- Radiology, Nuclear Medicine and Imaging 95
- Pharmaceutical Science 25
- Oncology 101
- Genetics 19
- Endocrinology, Diabetes and Metabolism 23
Countries citing papers authored by Kemal Balic
This map shows the geographic impact of Kemal Balic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemal Balic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemal Balic more than expected).
Fields of papers citing papers by Kemal Balic
This network shows the impact of papers produced by Kemal Balic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemal Balic. The network helps show where Kemal Balic may publish in the future.
Co-authors
The 25 scholars most cited alongside Kemal Balic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 73 | |
| 2 | 2021 | 55 | |
| 3 | 2020 | 20 | |
| 4 | 2020 | 9 | |
| 5 | 2020 | 9 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 6 | |
| 8 | 2010 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2018 | 2 | |
| 11 | 2018 | 2 | |
| 12 | 2018 | 2 | |
| 13 | 2022 | 0 |
About Kemal Balic
Kemal Balic is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Genetics, Oncology and Epidemiology, having authored 13 papers that have together received 192 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Fibroblast Growth Factor Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Neuropeptides and Animal Physiology (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Toxin Mechanisms and Immunotoxins (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (95 citations), Pharmaceutical Science (25 citations), Oncology (101 citations), Genetics (19 citations) and Endocrinology, Diabetes and Metabolism (23 citations). Kemal Balic has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Anton I. Rosenbaum, Meina Liang, Mayukh Das, Antoinette R. Tan, Manish R. Patel, Mark D. Pegram, Anna Maria Storniolo, Erika Hamilton, Shannon Marshall and Peng He. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics, Scientific Reports, Alimentary Pharmacology & Therapeutics and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.